ATP6AP2 and glioblastoma: The expression of RAS receptors (AGTR1, AGTR2, and ATP6AP2) has been demonstrated on the glioblastoma microvasculature [20,21], and the inhibition of AGTR1 or AGTR2 reduced glioblastoma cell growth in vitro and in vivo [19,22,23].